Subscribe to RSS

DOI: 10.1055/s-0045-1811238
Revisiting the Intracranial Neurological Imaging Manifestations of Human Immunodeficiency Virus: Pictorial Review with a Pattern-Based Approach
Funding None.
- Abstract
- Introduction
- Pattern-Based Approach
- References
Abstract
Human immunodeficiency virus (HIV) leads to a spectrum of pathologies from head to toe. This review focuses on the neurological complications associated with HIV infection. It highlights both direct effects, resulting from virus' direct impact on central nervous system (CNS), and indirect effects, stemming from progressive decline in CD4 counts. Direct effect encompasses HIV-associated neurocognitive disorder (HAND) and HIV-associated vasculopathy. Indirect effect comprises all the opportunistic infections that an individual is predisposed too, including toxoplasmosis, cryptococcal meningitis, and progressive multifocal leukoencephalopathy. Radiological imaging plays a crucial role in diagnosis and distinguishing of all these entities, which can have overlapped clinical presentation. The imaging characteristics are distinctive, such as, HAND presents with symmetrical bilateral white matter hyperintensities on magnetic resonance imaging, while cerebral toxoplasmosis typically shows a target sign with multiple ring enhancement, and cryptococcal meningitis has a typical “soap bubble appearance.” Meanwhile, progressive multifocal leukoencephalopathy is identified by asymmetric T2 hyperintensities without enhancement. This review also covers CNS-immune reconstitution inflammatory syndrome, a critical condition linked with antiretroviral therapy. This broad spectrum of presentation underscores the need for a systematic, pattern-based approach to enhance diagnostic accuracy, which is provided at the end.
Introduction
Human immunodeficiency virus (HIV) infection has widespread neurological implications, and leads to a spectrum of central nervous system (CNS) involvement. HIV-related neurological symptoms can be divided into two categories: (1) direct effects of HIV virus on the white matter and resulting encephalopathy and vasculopathy causing clinical deterioration, and (2) indirect effects of HIV on the CD4 counts leading to susceptibility to opportunistic infections, namely, toxoplasmosis (CNS-Toxo), JC virus infection resulting in progressive multifocal leukoencephalopathy (PML), fungal infections such as cryptococcosis (CNS-Crypt), and of course infection with various strains of Mycobacterium tuberculosis resulting in tuberculosis (CNS-TB), and development of primary CNS lymphoma (PCNSL; [Table 1]).[1] Lastly, neurological complication resulting from antiretroviral therapy (ART), immune reconstitution inflammatory syndrome (IRIS), also accounts for a significant portion of neurological complication.
CD4 count (cell/mm3) |
Frequently occurring CNS diseases |
---|---|
<50 |
Cytomegalovirus retinitis, primary CNS lymphoma, IRIS |
<200 |
HIV encephalopathy, toxoplasmosis, cryptococcosis, PML |
200–500 |
HIV encephalopathy |
>500 |
Tubercular infection |
Abbreviations: CNS, central nervous system; HIV, human immunodeficiency virus; IRIS, immune reconstitution inflammatory syndrome; PML, progressive multifocal leukoencephalopathy.
Despite being defined as distinct entities with an independent prognosis and specific management protocols, overlapping clinical features often complicate accurate diagnosis.
Thus, reaching a diagnosis with certainty can be an uphill task. Radiological imaging plays a pivotal role in diagnosing these conditions. By consolidating current knowledge and recent advancements in the field, this review underscores the crucial role of radiological imaging in differentiating these conditions; thus, bridging the gap between clinical symptomatology and definitive diagnosis. The systematic pattern-based approach aims to empower clinicians and radiologists to achieve early identification and appropriate management of HIV-related intracranial abnormalities, ultimately improving patient outcomes and enriching the scientific dialogue on neuro-HIV complication.
Direct Involvement by HIV Virus
HIV-Associated Neurocognitive Disorders (HAND)
Pathophysiology
The direct invasion of HIV into the CNS happens early in the disease, the virus persisting despite control of systemic viremia through a combination ART. This happens because many anti-HIV medications do not penetrate the blood–brain barrier, and HIV continues replicating in the brain.[2] The infection thus becomes chronic, inciting inflammation, neuronal injury, and synaptic dysfunction. Clinically no signs of cognitive impairment are present in the early stages of infection; however, diffuse myelin and axonal degradation sets in later and presents with cognitive symptoms termed HIV-associated neurocognitive disorders (HAND) in 30 to 50% patients. HIV-associated dementia is severe but milder neurocognitive impairment without dementia is often present. There are criteria specifying that two cognitive domains must be affected before labeling the HIV patient as HAND-positive.[3]
Imaging: Imaging shows symmetric bilateral T2 and FLAIR (fluid-attenuated inversion recovery) hyperintensities in the periventricular and deep white matter, and rarely in the subcortical white matter and the brainstem, along with diffuse cortical atrophy ([Fig. 1]).[4] Advanced imaging techniques, such as magnetic resonance spectroscopy (MRS) and diffusion tensor imaging (DTI), can assess the early changes of neuronal damage and also subsequent response to therapy.[5] MRS reveals lower N-acetyl aspartate (NAA) and higher myoinositol (mI) and choline (Cho) ratios, indicating neuronal loss and gliosis. DTI demonstrates an increase in mean diffusivity (MD) values and a decrease in fraction anisotropy (FA) values even when structural changes are not visible in the white matter on conventional MR sequences.


HIV-Associated Vasculopathy
Pathophysiology: HIV-associated inflammatory response and endothelial injury lead to vasculitis, stroke, and aneurysms/dissection.
Imaging: HIV vasculopathy mostly affects the small- to medium-sized arteries in the CNS. In young individuals, it typically causes multiple fusiform aneurysms and infractions from cerebral artery stenosis or occlusion. Cerebral angiitis resulting from vessel wall inflammation manifests on magnetic resonance (MR) as thickening and enhancement of the vessel wall on vessel wall imaging.[6] Computed tomography (CT) angiography and MR angiography are quite helpful in diagnosing this vascular manifestation of CNS-HIV. A representative case is shown in [Fig. 2].


Indirect involvement by HIV
Cerebral Toxoplasmosis
Pathophysiology: Reactivation of latent Toxoplasma gondii leads to focal necrotizing encephalitis in immunocompromised patients. Presence of clinical symptoms, the identification of one or more mass lesions on imaging, and detection of the parasite in clinical samples are necessary for a conclusive diagnosis of CNS-toxoplasmosis.[7]
Imaging: Lesions of toxoplasmosis appear hypodense on CT, are frequently accompanied by intense surrounding vasogenic edema, and demonstrate ring-like enhancement. Although isolated lesions are observed in 15 to 20% of cases,[4] multiple ring-enhancing lesions with adjacent vasogenic edema are the typical MR imaging (MRI) findings of CNS-toxoplasmosis ([Fig. 3]). Thalamus, cerebellum, subcortical white matter, and basal ganglia are the most often affected areas.[7] If the number of CD4-positive T cells in the serum is less than 50 cells/mm3, contrast enhancement might not be visible.


Pathognomonic imaging finding including target sign on T2-weighted images is characterized by concentric high- and low-signal areas with eccentric nodular target-like enhancement on contrast-enhanced T1-weighted imaging (T1WI) images.[8] The eccentric enhancing nodule represents a cluster of thickened vessels, whereas the ring represents the inflammatory vascular zone at the margin of the lesion, which has a necrotic center.[9] On susceptibility-weighted MRI, intralesional susceptibility signals, indicating areas of hemorrhages, can be seen in majority of cases ([Fig. 3D]).
Primary CNS Lymphoma
Pathophysiology: In HIV patients a high-grade B cell lymphoma associated with Epstein–Barr virus may occur. The incidence of PCNSL in HIV-infected individuals is 2 to 6%, almost 1,000 times higher than that in the general population.[10] Although ART has decreased the incidence of HIV-related PCNSL, it remains the most common HIV-associated malignancy.[11] Unless treated, the median survival of HIV-infected patients with PCNSL, after the onset of clinical symptoms, is 1 month.
Imaging: HIV-related PCNSL is characterized by lesions with a larger diameter (≥4 cm) than CNS-toxoplasmosis, with an almost equal chance of numerous and solitary lesions. They most typically involve the basal ganglia and corpus callosum.[12]
CT scan shows hyperdense lesions with homogeneous post-contrast enhancement, as in [Fig. 4(A)]. On MRI, the lesion appears as iso- to hypointense relative on T1WI, mostly hypointense on T2WI (T2-weighted imaging)/FLAIR images, and shows ring enhancement on post-contrast T1WI with areas of hemorrhage and necrosis, shown in [Fig. 4].


Lower apparent diffusion coefficient value, a greater choline/creatinine ratio on MRS, and a higher regional cerebral blood volume on MR perfusion in individuals with HIV-related PCNSL are effective in distinguishing HIV-related PCNSL from CNS-toxoplasmosis.[13]
Progressive Multifocal Leukoencephalopathy
Pathophysiology: This is caused by the JC virus, leading to demyelination of the white matter.[14] An initial JC virus infection in childhood typically persists in an asymptomatic carrier state in most individuals, and the virus can however reactivate in immunosuppressed patients.
Imaging: Asymmetric, nonenhancing T2/FLAIR hyperintensities, which are hypointense on T1W images, appear in the subcortical and in the periventricular white matter.[15] Decreased NAA and increased Cho and Mi values are seen on MRS due to damage to white matter and destruction of myelin.
PML lesions may be difficult to distinguish from tumefactive conditions like gliomatosis or demyelinating lesions such as multiple sclerosis on MRI. However, typically, the lesions show no mass effect or diffusion restriction on diffusion-weighted imaging (DWI) unlike gliomatosis cerebri. Multiple sclerosis lesions show increased MD and altered FA values due to anisotropy loss. T2WI shows front edge of demyelinating lesions in multifocal leukoencephalopathy appears faintly hyperintense with a large number of discrete, hyperintense spots of demyelination, an appearance similar to that of the Milky Way. The advancing edge of the lesion shows a hyperintense rim on DWI.[14] Another MR sign diagnostic and typical of PML is the “Shrimp sign” characterized by T2-hyperintensity in the cerebellar white matter abutting the middle cerebellar peduncle, but sparing the dentate nucleus.[16] Features are depicted in [Fig. 5(A, B)].


Cryptococcal Meningitis
Pathophysiology: Cryptococcus is a fungal species that enters the body by inhalation only to be removed by the host's defense mechanisms. But occasionally, particularly in immunocompromised HIV patients, it might result in pneumonia and subsequent CNS spread to cause meningoencephalitis.
Imaging: Meningitis or meningoencephalitis is the major feature of CNS cryptococcosis. Another appearance often seen is when the infection spreads via the perivascular spaces, where gelatinous mucoid cryptococcal capsular polysaccharides and budding yeast build up in the dilated perivascular spaces, forming tiny gelatinous pseudocysts, as shown in [Fig. 6A(a)]. These have a typical “soap bubble appearance” on MRI, with intermediate signal on T1W images, high signal on T2WI, and suppression on FLAIR images.[17] These gelatinous pseudocysts are commonly seen in the basal ganglia, thalamus, and midbrain. When there is immunological response from ART administration, imaging may show cryptococcoma and nodular meningeal enhancement similar to what is observed in granulomatous disorders like tuberculosis, sarcoidosis, etc. as shown in [Fig. 6B(b–d)] [4].


Tuberculous Meningitis
Pathophysiology: Hematogenous spread of M. tuberculosis in an immunocompromised HIV patient results in involvement of meninges or cerebral parenchyma and tubercular abscess formation.[4]
Imaging: Although imaging findings in HIV and non-HIV-associated CNS-TB are essentially identical, meningitis is more common in persons infected with HIV. Inflammation of small blood vessels, e.g., lenticulostriate branches, causes vasospasm, resulting in the infarction predominantly seen in bilateral basal ganglia.
Classic imaging findings in patients with tubercular meningitis (TBM) include communicating hydrocephalus (75%), basilar exudates (38%), periventricular infarctions (15–30%), and cerebral parenchymal tuberculomas (5–10%).[18] Caseating tuberculomas shows a T2WI hypointense rim, with restriction on DWI and ring enhancement on post-contrast TIWI, while noncaseating tuberculoma shows homogenous nodular enhancement.[4] Imaging detailed in [Fig. 7].


Immune Reconstitution Inflammatory Syndrome
Pathophysiology: IRIS is an exuberant inflammatory response to an underlying antigen. In patients of HIV, a variable onset is noted, ranging from weeks to years, after the initiation of highly active ART. Those with baseline CD4 count <50 cells are at increased risk. Patient usually presents with worsening of the existing symptoms or development of new symptoms despite adequate therapy. In most cases, this inflammatory response is mild and self-limiting; however, in some individuals a fulminant manifestation can be observed, causing rapid worsening of patient's symptoms and eventually death shortly after onset. With such uncertain course, and incidence reported to be as high as 25 to 35%, its importance cannot be undermined.[19]
Imaging: diverse clinical presentation and imaging manifestation of CNS-IRIS make it difficult to diagnose. MRI shows an increase in the parenchymal abnormalities on FLAIR, mass effect, and diffusion restriction. On post-contrast scan, enhancement of parenchymal abnormality usually points toward CNS-IRIS, in appropriate clinical settings.[19]
[Figs. 8(A, B)] and [9] present representative cases of CNS-IRIS, PML-IRIS, and TB-IRIS respectively, reproduced with permission of the respective authors.




Pattern-Based Approach
Radiological imaging is pivotal in the diagnosis, differentiation, and management of intracranial complications associated with HIV. Each condition presents with unique imaging characteristics which, when correctly interpreted, can significantly influence clinical outcomes.
Thus, we provide a pattern-based approach to CNS pathologies in HIV patients in [Table 2].
Abbreviations: ACA, anterior cerebral artery; CNS, central nervous system; FLAIR, fluid-attenuated inversion recovery; HAND, HIV-associated neurocognitive disorder; HIV, human immunodeficiency virus; IRIS, immune reconstitution inflammatory syndrome; MCA, middle cerebral artery; MIP, maximum intensity projection; PCA, posterior cerebral artery; PML, progressive multifocal leukoencephalopathy.
Conflict of Interest
None declared.
Authors' Contributions
Conceptualization: D.V., S.M., and L.B.
Formal analysis and investigation: D.V., S.M., and L.B.
Methodology: D.V., S.M., and L.B.
Validation: D.V., S.M., and L.B.
Writing—original draft: D.V., S.M., and L.B.
Writing—review and editing: D.V., S.M., and L.B.
Supervision: D.V., S.M., and L.B.
Ethical Approval
Ethical approval was waived by the local Ethics Committee of ABVIMS and Dr. RML Hospital, New Delhi, in view of the retrospective nature of the study and all the procedures being performed were part of the routine care.
Patients' Consent
Informed consent was obtained from all individual participants included in the study.
* Co-first authors, in view of equal contribution towards the manuscript.
-
References
- 1 Jung AC, Paauw DS. Diagnosing HIV-related disease: using the CD4 count as a guide. J Gen Intern Med 1998; 13 (02) 131-136
- 2 Saylor D, Dickens AM, Sacktor N. et al. HIV-associated neurocognitive disorder–pathogenesis and prospects for treatment. Nat Rev Neurol 2016; 12 (04) 234-248
- 3 Saloner R, Cysique LA. HIV-associated neurocognitive disorders: a global perspective. J Int Neuropsychol Soc 2017; 23 (9–10): 860-869
- 4 Smith AB, Smirniotopoulos JG, Rushing EJ. From the archives of the AFIP: central nervous system infections associated with human immunodeficiency virus infection: radiologic-pathologic correlation. Radiographics 2008; 28 (07) 2033-2058
- 5 Clifford DB, Ances BM. HIV-associated neurocognitive disorder. Lancet Infect Dis 2013; 13 (11) 976-986
- 6 Benjamin LA, Allain TJ, Mzinganjira H. et al. The role of human immunodeficiency virus-associated vasculopathy in the etiology of stroke. J Infect Dis 2017; 216 (05) 545-553
- 7 National Institutes of Health; Centers for Disease Control and Prevention; HIV Medicine Association of the Infectious Diseases Society of America Panel on Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV— A Working Group of the Office of AIDS Research Advisory Council (OARAC). Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. [Updated 2025 Jul 14]. In: ClinicalInfo.HIV.gov [Internet]. Rockville (MD): US Department of Health and Human Services; 2002-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK586304/
- 8 Mahadevan A, Ramalingaiah AH, Parthasarathy S, Nath A, Ranga U, Krishna SS. Neuropathological correlate of the “concentric target sign” in MRI of HIV-associated cerebral toxoplasmosis. J Magn Reson Imaging 2013; 38 (02) 488-495
- 9 Masamed R, Meleis A, Lee EW, Hathout GM. Cerebral toxoplasmosis: case review and description of a new imaging sign. Clin Radiol 2009; 64 (05) 560-563
- 10 Young RJ, Ghesani MV, Kagetsu NJ, Derogatis AJ. Lesion size determines accuracy of thallium-201 brain single-photon emission tomography in differentiating between intracranial malignancy and infection in AIDS patients. AJNR Am J Neuroradiol 2005; 26 (08) 1973-1979
- 11 Gupta NK, Nolan A, Omuro A. et al. Long-term survival in AIDS-related primary central nervous system lymphoma. Neuro-oncol 2017; 19 (01) 99-108
- 12 Haldorsen IS, Espeland A, Larsson EM. Central nervous system lymphoma: characteristic findings on traditional and advanced imaging. AJNR Am J Neuroradiol 2011; 32 (06) 984-992
- 13 Camacho DL, Smith JK, Castillo M. Differentiation of toxoplasmosis and lymphoma in AIDS patients by using apparent diffusion coefficients. AJNR Am J Neuroradiol 2003; 24 (04) 633-637
- 14 Berger JR, Aksamit AJ, Clifford DB. et al. PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section. Neurology 2013; 80 (15) 1430-1438
- 15 Sakai M, Inoue Y, Aoki S. et al. Follow-up magnetic resonance imaging findings in patients with progressive multifocal leukoencephalopathy: evaluation of long-term survivors under highly active antiretroviral therapy. Jpn J Radiol 2009; 27 (02) 69-77
- 16 Adra N, Goodheart AE, Rapalino O. et al. MRI shrimp sign in cerebellar progressive multifocal leukoencephalopathy: description and validation of a novel observation. AJNR Am J Neuroradiol 2021; 42 (06) 1073-1079
- 17 Zhang P, Lian L, Wang F. Magnetic resonance imaging features of gelatinous pseudocysts in cryptococcal meningoencephalitis. Acta Neurol Belg 2019; 119 (02) 265-267
- 18 Hasuo K, Takahashi N, Futoshi M. et al. Radiological diagnosis of tuberculous, fungal, and parasitic infections in the central nervous system. Nichidoku-Iho. 2002; 47: 285-297
- 19 Post MJ, Thurnher MM, Clifford DB. et al. CNS-immune reconstitution inflammatory syndrome in the setting of HIV infection, part 2: discussion of neuro-immune reconstitution inflammatory syndrome with and without other pathogens. AJNR Am J Neuroradiol 2013; 34 (07) 1308-1318
- 20 Baheerathan A, McNamara C, Kalam S. et al. The utility of FDG-PET imaging in distinguishing PML-IRIS from PML in a patient treated with natalizumab. Neurology 2018; 91 (12) 572-573
- 21 Christian E, Johnston A. CNS TB-IRIS following cessation of adalimumab in an adolescent with Crohn's disease. Open Forum Infect Dis 2022; 9 (08) ofac367
Address for correspondence
Publication History
Article published online:
18 August 2025
© 2025. Indian Radiological Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Jung AC, Paauw DS. Diagnosing HIV-related disease: using the CD4 count as a guide. J Gen Intern Med 1998; 13 (02) 131-136
- 2 Saylor D, Dickens AM, Sacktor N. et al. HIV-associated neurocognitive disorder–pathogenesis and prospects for treatment. Nat Rev Neurol 2016; 12 (04) 234-248
- 3 Saloner R, Cysique LA. HIV-associated neurocognitive disorders: a global perspective. J Int Neuropsychol Soc 2017; 23 (9–10): 860-869
- 4 Smith AB, Smirniotopoulos JG, Rushing EJ. From the archives of the AFIP: central nervous system infections associated with human immunodeficiency virus infection: radiologic-pathologic correlation. Radiographics 2008; 28 (07) 2033-2058
- 5 Clifford DB, Ances BM. HIV-associated neurocognitive disorder. Lancet Infect Dis 2013; 13 (11) 976-986
- 6 Benjamin LA, Allain TJ, Mzinganjira H. et al. The role of human immunodeficiency virus-associated vasculopathy in the etiology of stroke. J Infect Dis 2017; 216 (05) 545-553
- 7 National Institutes of Health; Centers for Disease Control and Prevention; HIV Medicine Association of the Infectious Diseases Society of America Panel on Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV— A Working Group of the Office of AIDS Research Advisory Council (OARAC). Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. [Updated 2025 Jul 14]. In: ClinicalInfo.HIV.gov [Internet]. Rockville (MD): US Department of Health and Human Services; 2002-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK586304/
- 8 Mahadevan A, Ramalingaiah AH, Parthasarathy S, Nath A, Ranga U, Krishna SS. Neuropathological correlate of the “concentric target sign” in MRI of HIV-associated cerebral toxoplasmosis. J Magn Reson Imaging 2013; 38 (02) 488-495
- 9 Masamed R, Meleis A, Lee EW, Hathout GM. Cerebral toxoplasmosis: case review and description of a new imaging sign. Clin Radiol 2009; 64 (05) 560-563
- 10 Young RJ, Ghesani MV, Kagetsu NJ, Derogatis AJ. Lesion size determines accuracy of thallium-201 brain single-photon emission tomography in differentiating between intracranial malignancy and infection in AIDS patients. AJNR Am J Neuroradiol 2005; 26 (08) 1973-1979
- 11 Gupta NK, Nolan A, Omuro A. et al. Long-term survival in AIDS-related primary central nervous system lymphoma. Neuro-oncol 2017; 19 (01) 99-108
- 12 Haldorsen IS, Espeland A, Larsson EM. Central nervous system lymphoma: characteristic findings on traditional and advanced imaging. AJNR Am J Neuroradiol 2011; 32 (06) 984-992
- 13 Camacho DL, Smith JK, Castillo M. Differentiation of toxoplasmosis and lymphoma in AIDS patients by using apparent diffusion coefficients. AJNR Am J Neuroradiol 2003; 24 (04) 633-637
- 14 Berger JR, Aksamit AJ, Clifford DB. et al. PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section. Neurology 2013; 80 (15) 1430-1438
- 15 Sakai M, Inoue Y, Aoki S. et al. Follow-up magnetic resonance imaging findings in patients with progressive multifocal leukoencephalopathy: evaluation of long-term survivors under highly active antiretroviral therapy. Jpn J Radiol 2009; 27 (02) 69-77
- 16 Adra N, Goodheart AE, Rapalino O. et al. MRI shrimp sign in cerebellar progressive multifocal leukoencephalopathy: description and validation of a novel observation. AJNR Am J Neuroradiol 2021; 42 (06) 1073-1079
- 17 Zhang P, Lian L, Wang F. Magnetic resonance imaging features of gelatinous pseudocysts in cryptococcal meningoencephalitis. Acta Neurol Belg 2019; 119 (02) 265-267
- 18 Hasuo K, Takahashi N, Futoshi M. et al. Radiological diagnosis of tuberculous, fungal, and parasitic infections in the central nervous system. Nichidoku-Iho. 2002; 47: 285-297
- 19 Post MJ, Thurnher MM, Clifford DB. et al. CNS-immune reconstitution inflammatory syndrome in the setting of HIV infection, part 2: discussion of neuro-immune reconstitution inflammatory syndrome with and without other pathogens. AJNR Am J Neuroradiol 2013; 34 (07) 1308-1318
- 20 Baheerathan A, McNamara C, Kalam S. et al. The utility of FDG-PET imaging in distinguishing PML-IRIS from PML in a patient treated with natalizumab. Neurology 2018; 91 (12) 572-573
- 21 Christian E, Johnston A. CNS TB-IRIS following cessation of adalimumab in an adolescent with Crohn's disease. Open Forum Infect Dis 2022; 9 (08) ofac367

















